Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 176

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network

Open access
van de Donk, N. W. C. J., Palumbo, A., Johnsen, H. E., Engelhardt, M., Gay, F., Gregersen, H., Hajek, R., Kleber, M., Ludwig, H., Morgan, G., Musto, P., Plesner, T., Sezer, O., Terpos, E., Waage, A., Zweegman, S., Einsele, H., Sonneveld, P., Lokhorst, H. M., on behalf of the European Myeloma Network · 2014 · Haematologica

Abstract

Monoclonal gammopathy of undetermined significance is one of the most common pre-malignant disorders. IgG and IgA monoclonal gammopathy of undetermined significance are precursor conditions of multiple myeloma; light-chain monoclonal gammopathy of undetermined significance of light-chain multiple myeloma; and IgM monoclonal gammopathy of undetermined significance of Waldenström's macroglobulinemia and other lymphoproliferative disorders. Clonal burden, as determined by bone marrow plasma cell percentage or M-protein level, as well as biological characteristics, including heavy chain isotype and light chain production, are helpful in predicting risk of progression of monoclonal gammopathy of undetermined significance to symptomatic disease. Furthermore, alterations in the bone marrow microenvironment of monoclonal gammopathy of undetermined significance patients result in an increased risk of venous and arterial thrombosis, infections, osteoporosis, and bone fractures. In addition, the small clone may occasionally be responsible for severe organ damage through the production of a monoclonal protein that has autoantibody activity or deposits in tissues. These disorders are rare and often require therapy directed at eradication of the underlying plasma cell or lymphoplasmacytic clone. In this review, we provide an overview of the clinical relevance of monoclonal gammopathy of undetermined significance. We also give general recommendations of how to diagnose and manage patients with monoclonal gammopathy of undetermined significance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3324/haematol.2013.100552

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 176

Metadata

Authors
van de Donk, N. W. C. J., Palumbo, A., Johnsen, H. E., Engelhardt, M., Gay, F., Gregersen, H., Hajek, R., Kleber, M., Ludwig, H., Morgan, G., Musto, P., Plesner, T., Sezer, O., Terpos, E., Waage, A., Zweegman, S., Einsele, H., Sonneveld, P., Lokhorst, H. M., & on behalf of the European Myeloma Network
Venue
Haematologica
Published
2014-03-21
Volume
99
Issue
6
Pages
984-996
ISSN
  • 0390-6078 (ISSN-L)
  • 1592-8721
OpenAlex
W2076166403
Cited by
176
References
5
FWCI
8.16
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network. https://app.cochat.ai/papers/10.3324/haematol.2013.100552
The paper
van de Donk, N. W. C. J., Palumbo, A., Johnsen, H. E., Engelhardt, M., Gay, F., Gregersen, H., Hajek, R., Kleber, M., Ludwig, H., Morgan, G., Musto, P., Plesner, T., Sezer, O., Terpos, E., Waage, A., Zweegman, S., Einsele, H., Sonneveld, P., Lokhorst, H. M., & on behalf of the European Myeloma Network. (2014). The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network. Haematologica. https://doi.org/10.3324/haematol.2013.100552

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.